Search Count: 5
 |
Rip2 Kinase Catalytic Domain Complex With 2(4[(1,3Benzothiazol5Yl)Amino]6(2Methylpropane2Sulfonyl)Quinazolin7Yl)Oxy)Ethyl Phosphate
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.69 Å Release Date: 2019-07-17 Classification: TRANSFERASE Ligands: K9T, CA |
 |
Rip2 Kinase Catalytic Domain Complex With 2({4[(1,3Benzothiazol5Yl)Amino]6(2Methylpropane2Sulfonyl)Quinazolin7Yl}Oxy)Ethan1Ol
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.62 Å Release Date: 2019-07-17 Classification: TRANSFERASE Ligands: KA2 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.56 Å Release Date: 2017-07-05 Classification: transferase/transferase inhibitor Ligands: 7MJ |
 |
The Identification And Pharmacological Characterization Of 6-(Tert-Butylsulfonyl)-N-(5-Fluoro-1H-Indazol-3-Yl)Quinolin-4-Amine (Gsk583), A Highly Potent And Selective Inhibitor Of Rip2 Kinase, Compound 3 Complex
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.69 Å Release Date: 2016-05-18 Classification: Transferase/Transferase Inhibitor Ligands: 6GE, SO4 |
 |
The Identification And Pharmacological Characterization Of 6-(Tert-Butylsulfonyl)-N-(5-Fluoro-1H-Indazol-3-Yl)Quinolin-4-Amine (Gsk583), A Highly Potent And Selective Inhibitor Of Rip2 Kinase, Gsk583 Complex
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.53 Å Release Date: 2016-05-18 Classification: Transferase/Transferase Inhibitor Ligands: 6GD |